Linkstr. 10
Berlin, Berlin 10785
Germany
Pfizer Pharma GmbH
CAP, Community acquired pneumonia, Medical claims study, pneumonia, pneumococcus, Streptococcus pneumoniae, attributable fatality, attributable costs, medical costs, social costs, Case fatality, longitudinal study, CFR
pneumococcal vaccination rates, immunocompromised patients, sequential pneumococcal vaccination
Pneumococcal, conjugate vaccines, Pneumoccocal serotype dynamic, mathematical modelling